Careplus Group Berhad Valuation
Is CAREPLS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 4/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CAREPLS?
Other financial metrics that can be useful for relative valuation.
|What is CAREPLS's n/a Ratio?|
Price to Sales Ratio vs Peers
How does CAREPLS's PS Ratio compare to its peers?
|Company||PS||Estimated Growth||Market Cap|
COMFORT Comfort Gloves Berhad
ADVENTA Adventa Berhad
KOSSAN Kossan Rubber Industries Bhd
SUPERMX Supermax Corporation Berhad
CAREPLS Careplus Group Berhad
Price-To-Sales vs Peers: CAREPLS is good value based on its Price-To-Sales Ratio (0.7x) compared to the peer average (0.8x).
Price to Earnings Ratio vs Industry
How does CAREPLS's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?
Price to Sales Ratio vs Fair Ratio
What is CAREPLS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||0.7x|
|Fair PS Ratio||n/a|
Price-To-Sales vs Fair Ratio: Insufficient data to calculate CAREPLS's Price-To-Sales Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of CAREPLS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CAREPLS (MYR0.48) is trading below our estimate of fair value (MYR0.66)
Significantly Below Fair Value: CAREPLS is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.